Increases in recent prescription drug spending are driven by market incentives to raise drug prices and structural changes to Medicare and Medicaid drug benefits. This deep dive explores approaches to addressing root causes of rising expenditures so payers and patients will have access to quality medications at the lowest reasonable costs.

Rural healthcare centers are under-equipped to handle a higher need and more dispersed patient population. This deep dive explores solutions for reducing provider administrative burden so they are better able to serve their patients.

COVID-19 exposed the vulnerabilities of US reliance on international markets for pharmaceutical inputs and manufacturing, resulting in drug shortages and increased costs. This deep dive explores how the US can build supply chain resilience for pharmaceutical products to better ensure patients have access to life-saving treatment.